Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Life Science

• Publication date

  1998-01-16

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(97)01175-2PMID 9489513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.

  1997cited by this paper
• Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

  1997cited by this paper
• Covalent bonding of heparin to a vinyl copolymer for biomedical applications.

  1997cited by this paper
• Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators.

  1996cited by this paper
• Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum

  1996cited by this paper
• Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG.

  1995cited by this paper
• Activation of the complement system by polysaccharidic surfaces bearing carboxymethyl, carboxymethylbenzylamide and carboxymethylbenzylamide sulphonate groups.

  1995cited by this paper
• Colloidal Drug Delivery Systems

  1994cited by this paper
• Biodegradable long-circulating polymeric nanospheres.

  1994cited by this paper
• Strategy for in vitro evaluation of the interactions between biomaterials and complement system

  1993cited by this paper
• Complement activation by polymethyl methacrylate minimized by end-point heparin attachment.

  1993cited by this paper
• Activators and inhibitors of Complement

  1993cited by this paper
• Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migration.

  1992cited by this paper
• Sterically stabilized liposomes.

  1992cited by this paper
• Heparin and Related Polysaccharides

  1992cited by this paper
• Protein—surface interactions in the presence of polyethylene oxide

  1991cited by this paper
• Specific antibodies enhance alternative complement pathway activation by cuprophane.

  1991cited by this paper
• Heparin-like Polymer Surfaces: Control of Coagulation and Complement Activation by Insoluble Functionalized Polymers

  1990cited by this paper
• Intraocular PMMA lenses modified with surface-immobilized heparin: evaluation of biocompatibility in vitro and in vivo.

  1989cited by this paper
• Comparison of the activity of polyanions and polycations on the classical and alternative pathways of complement.

  1989cited by this paper
• The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives.

  1988cited by this paper
• Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum.

  1988cited by this paper
• Large unilamellar liposomes with low uptake into the reticuloendothelial system

  1987cited by this paper
• Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b

  1979cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper

• Advances in the biosynthesis of heparosan, a key precursor of heparin

  2025cites this paper
• Diversely substituted poly(N-vinyl amide) derivatives towards non-toxic, stealth and pH-responsive lipid nanocapsules.

  2024cites this paper
• Purification processes of polymeric nanoparticles: How to improve their clinical translation?

  2023cites this paper
• Nanomedicine approaches and strategies for gum-based stealth nanocarriers

  2022cites this paper
• Targeted Drug Delivery: Advancements, Applications, and Challenges

  2021cites this paper
• Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors

  2021cites this paper
• pH-Responsive Lipid Nanocapsules: A Promising Strategy for Improved Resistant Melanoma Cell Internalization

  2021cites this paper
• What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

  2021cites this paper
• A self assembled dextran-stearic acid-spermine nanocarrier for delivery of rapamycin as a hydrophobic drug

  2021cites this paper
• Heparin length in the coating of extremely small iron oxide nanoparticles regulates in vivo theranostic applications.

  2020cites this paper
• A Novel Anti‐Coagulative Nanocomplex in Delivering miRNA‐1 Inhibitor Against Microvascular Obstruction of Myocardial Infarction

  2020cites this paper
• Understanding Nanomedicine Size and Biological Response Dependency: What Is the Relevance of Previous Relationships Established on Only Batch-Mode DLS-Measured Sizes?

  2020cites this paper
• Drug carrier systems made from self-assembled glyco-nanoparticles of maltoheptaose-b-polyisoprene enhanced the distribution and activity of curcumin against cancer cells

  2020cites this paper
• Recent advances in the targeting of systemically administered non-viral gene delivery systems

  2019cites this paper
• Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria.

  2019cites this paper
• Pharmaceutical applications of natural polysaccharides

  2019cites this paper
• Nanoparticles for improvement in oral bioavailability

  2019cites this paper
• Main Chain Polysulfoxides as Active ‘Stealth’ Polymers with Additional Antioxidant and Anti-Inflammatory Behaviour

  2019cites this paper
• In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles

  2018cites this paper
• Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success

  2018cites this paper
• Title Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling

  2018cites this paper
• Drug and Gene Delivery to the Central Nervous System for Neuroprotection

  2017cites this paper
• Efficacy of vinyl imidazole grafted cationized pullulan and dextran as gene delivery vectors: A comparative study.

  2017cites this paper
• Heparin: new life for an old drug.

  2017cites this paper
• Caractérisation des nanomédecines pour la clinique : développement de méthodes évaluant les interactions nanoparticules-protéines plasmatiques pour une application en contrôle qualité. (Nanomedicine characterization for the clinics : development of methods evaluating the interactions nanoparticles-p

  2017cites this paper
• Surface Modification of Polysaccharide-Based Nanoparticles with PEG and Dextran and the Effects on Immune Cell Binding and Stimulatory Characteristics.

  2017cites this paper
• Renewable Biomaterials as Nanocarriers for Drug and Gene Delivery

  2017cites this paper
• Nanomedicine as a potent strategy in melanoma tumor microenvironment

  2017cites this paper
• Highlights in Endocytosis of Nanostructured Systems.

  2017cites this paper
• Application of Nanoparticles as a Drug Delivery System

  2017cites this paper
• Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.

  2017cites this paper
• 1 Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR 4 – NF-B signaling

  2017cites this paper
• Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake.

  2016cites this paper
• Shielding Therapeutic Drug Carriers from the Mononuclear Phagocyte System: A Review.

  2016cites this paper
• Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications

  2016cites this paper
• Opportunities for glyconanomaterials in personalized medicine.

  2016cites this paper
• Heparin: Past, Present, and Future

  2016cites this paper
• The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications.

  2016cites this paper
• Polysaccharide-Based Nanoparticles as Drug Delivery Systems

  2016cites this paper
• Serial multiple crossed immunoelectrophoresis at a microscale: A stamp‐sized 2D immunoanalysis of protein C3 activation caused by nanoparticles

  2016cites this paper
• Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking

  2016cites this paper
• Smart Nanopolysaccharides for the Delivery of Bioactives

  2016cites this paper
• Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

  2016cites this paper
• Retracted: Multifunctional Polymeric Nanosystems for Dual‐Targeted Combinatorial Chemo/Antiangiogenesis Therapy of Tumors

  2016cites this paper
• The protein corona of polymeric nanocarriers: characterization and impact on cellular uptake

  2015cites this paper
• Advanced nanocarriers based on heparin and its derivatives for cancer management.

  2015cites this paper
• Design attributes of long-circulating polymeric drug delivery vehicles.

  2015cites this paper
• Heparin-based nanocapsules as potential drug delivery systems.

  2015cites this paper
• Engineered nanoparticles for drug delivery in cancer therapy.

  2014cites this paper
• Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry.

  2014cites this paper
• Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie

  2014cites this paper
• Biological barriers and current strategies for modifying nanoparticle bioavailability.

  2014cites this paper
• Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.

  2014cites this paper
• Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles.

  2014cites this paper
• Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery.

  2014cites this paper
• Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling.

  2014cites this paper
• Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.

  2013cites this paper
• In vitro and in vivo evaluation of superparamagnetic iron oxide nanoparticles coated by bisphosphonates: the effects of electrical charge and molecule length.

  2013cites this paper
• The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.

  2013cites this paper
• Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.

  2013cites this paper
• Cellular Uptake and Intracellular Cargo Release From Dextran Based Nanogel Drug Carriers.

  2013cites this paper
• Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects.

  2013influential citation
• Cellular uptake and activity of heparin functionalised cerium oxide nanoparticles in monocytes.

  2013cites this paper
• Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative.

  2012cites this paper
• Polysaccharides as Nanomaterials for Therapeutics

  2012cites this paper
• Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

  2012cites this paper
• Targeted Delivery Using Biodegradable Polymeric Nanoparticles

  2012cites this paper
• LAYER-BY-LAYER ASSEMBLY OF THE POLYELECTROLYTES ON MESOPOROUS SILICON NANOPARTICLES

  2012cites this paper
• The Interactions between Blood and Polymeric Nanoparticles Depend on the Nature and Structure of the Hydrogel Covering the Surface

  2012cites this paper
• Nanoparticles Based on Modified Polysaccharides

  2012cites this paper
• Application of polysaccharides for surface modification of nanomedicines.

  2012cites this paper
• Recent Progress in Polymer Therapeutics as Nanomedicines

  2012cites this paper
• Macromolecular surfactants synthesized by lipase-catalyzed transesterification of dextran with vinyl decanoate

  2012cites this paper
• Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation

  2011cites this paper
• Complement activation by carbon nanotubes.

  2011cites this paper
• Surface plasmon resonance in monitoring of complement activation on biomaterials.

  2011cites this paper
• Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect

  2011cites this paper
• Stealth properties of poly(ethylene oxide)-based triblock copolymer micelles: a prerequisite for a pH-triggered targeting system.

  2011cites this paper
• CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction.

  2011cites this paper
• Design of reversibly core cross-linked micelles sensitive to reductive environment.

  2011cites this paper
• Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation

  2011cites this paper
• Stealth macromolecular platforms for the design of MRI blood pool contrast agents

  2011cites this paper
• Convenient grafting through approach for the preparation of stealth polymeric blood pool magnetic resonance imaging contrast agents

  2011cites this paper
• A new generation of polymer nanoparticles for drug delivery.

  2010cites this paper
• Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.

  2010cites this paper
• LONG-CIRCULATING DNA LIPID NANOCAPSULES AS NEW VECTOR FOR PASSIVE TUMOR TARGETING Morille

  2010influential citation
• Complement activation on surfaces carrying hydroxyl or amino groups

  2010cites this paper
• The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

  2010cites this paper
• Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

  2010cites this paper
• Polysaccharide-based Polyion Complex Micelles as New Delivery Systems for HydrophilicCationic Drugs

  2010cites this paper
• Mise au point de nanoparticules polymères pour l'administration parentérale d'agents anticancéreux hydrophobes

  2010cites this paper
• Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.

  2010influential citation
• Nanoparticulate carriers (NPC) for oral pharmaceutics and nutraceutics.

  2010cites this paper
• Polymer micelles decorated by gadolinium complexes as MRI blood contrast agents: design, synthesis and properties

  2010cites this paper
• Effect of swelling of poly(vinyl alcohol) layers on complement activation.

  2010cites this paper
• The effect of PMMA stimulated Complement-Macrophage cascade on Osteogenesis of Preosteoblast-like MC3T3-E1 cells on PMMA surface

  2010cites this paper
• Integrated Development of Glycobiologics: From Discovery to Applications in the Design of Nanoparticular Drug Delivery Systems

  2010cites this paper
• Stealth nanoparticles coated with heparin as peptide or protein carriers

  2009cites this paper
• PEGylated degradable composite nanoparticles based on mixtures of PEG-b-poly(γ-benzyl L-glutamate) and poly(γ-benzyl L-glutamate).

  2009cites this paper
• Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug.

  2009cites this paper